RLFTF — MindMaze Therapeutics Holding SA
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1854078 ·
Switzerland
Last close
$0.26
Market Cap
$3.34M
52W High
$0.56
52W Low
$0.16
ADV30
4,587
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2025 | — | — | — | — | 47,987,000 | 12,500,000 | 15,354,000 |
| Dec 2024 | — | — | — | — | 53,224,000 | 15,080,000 | 16,560,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-240,222,000
Inventory
$923,000
Receivables
$1,468,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$642,000
EBITDA
$-9,143,000
Free Cash Flow
—
Enterprise Value
—
Total Cash
—
Total Debt
—
Shares Out
12,591,919
Trailing EPS
$-1.70
Book Value
$0.31
ROE
-51.6%
ROA
-25.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 8,417,000 | -7,906,000 | -17,119,000 | 53,224,000 | 16,560,000 | — | -2,916,000 |
| Dec 2023 | 6,033,000 | -19,778,000 | -98,181,000 | 76,390,000 | 24,162,000 | — | -17,612,000 |
| Dec 2022 | 6,081,000 | -35,474,000 | -50,790,000 | 188,798,000 | 43,381,000 | — | -24,126,000 |
| Dec 2021 | 3,321,000 | -34,611,000 | -34,705,000 | 251,618,000 | 70,088,000 | — | -35,718,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | $3.34M | $0.06 | — |
| UPC | Universe Pharmaceuticals INC | $3.35M | $5.30 | — |
| GOVX | GeoVax Labs, Inc. | $3.37M | $0.65 | — |
| GNPX | Genprex, Inc. | $3.24M | $3.95 | — |
| ARTL | ARTELO BIOSCIENCES, INC. | $3.18M | $0.69 | — |
News headlines (Yahoo Finance, 1h cache)
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
2025-12-23 06:20 · Yahoo
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
2025-12-15 06:20 · Yahoo
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
2025-11-14 17:40 · Yahoo
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
2025-10-29 06:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.